Skip to Content
Merck
CN

250031

(R)-(−)-N-(3,5-Dinitrobenzoyl)-α-phenylglycine

99%, for peptide synthesis

Synonym(s):

N-(3,5-Dinitrobenzoyl)-D-α-phenylglycine, R-(−)-N-(3,5-Dinitrobenzoyl)phenylglycine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
(O2N)2C6H3CONHCH(C6H5)CO2H
CAS Number:
Molecular Weight:
345.26
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352209
MDL number:
Beilstein/REAXYS Number:
4719763
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

(R)-(−)-N-(3,5-Dinitrobenzoyl)-α-phenylglycine, 99%

assay

99%

optical activity

[α]20/D −102°, c = 0.9 in THF

reaction suitability

reaction type: solution phase peptide synthesis

mp

216-217 °C (lit.)

application(s)

peptide synthesis

SMILES string

OC(=O)[C@H](NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O)c2ccccc2

InChI

1S/C15H11N3O7/c19-14(16-13(15(20)21)9-4-2-1-3-5-9)10-6-11(17(22)23)8-12(7-10)18(24)25/h1-8,13H,(H,16,19)(H,20,21)/t13-/m1/s1

InChI key

MIVUDAUOXJDARR-CYBMUJFWSA-N



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Resolution of enantiomers of 19-hydroxyeicosatetraenoate and 18-hydroxyeicosatetraenoate by chiral phase high-performance liquid chromatography of naphthoyl ester derivatives.
E H Oliw
Journal of chromatography, 526(2), 525-529 (1990-04-06)
Wolfgang Thormann et al.
Journal of pharmaceutical and biomedical analysis, 27(3-4), 555-567 (2002-01-05)
The electrokinetic separation and analysis of the enantiomers of albendazole sulfoxide (ABZSO), a sulfoxide with a sulfur stereogenic center hepatically formed during therapy with the anthelmintic drug albendazole (ABZ), is reported. Using aqueous or nonaqueous alkaline background electrolytes, ABZSO enantiomers
K Roy et al.
Drug design and discovery, 17(4), 315-323 (2002-01-05)
QSAR analyses of matrix metalloproteinase (MMP) inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates, recently reported by Scozzafava and Supuran, have been attempted using linear free energy related (LFER) model of Hansch to explore the contribution patterns of the phenyl ring substitutions (P1' anchoring



Global Trade Item Number

SKUGTIN
250031-5G04061838347992